Artiva Biotherapeutics, Inc. (ARTV) ownership: Top institutional holder: RA CAPITAL MANAGEMENT, L.P. ($63.46M). Insider activity: Net Seller (5 buys, 15 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 9853302.00 | $63.46M | 2026-03-31 |
| 5AM Venture Management, LLC | 2353304.00 | $15.16M | 2026-03-31 |
| Venrock Adviser, LLC | 1609569.00 | $10.37M | 2026-03-31 |
| venBio Partners LLC | 531337.00 | $3.42M | 2026-03-31 |
| FRANKLIN RESOURCES INC | 520327.00 | $3.35M | 2026-03-31 |
| Revelation Capital Management, LLC | 299311.00 | $1.93M | 2026-03-31 |
| BlackRock, Inc. | 213388.00 | $1.37M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 207686.00 | $1.34M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Buy | null | 2026-06-09 | |
| Buy | null | 2026-06-09 | |
| Buy | null | 2026-06-09 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 |
Back to ARTV overview · ARTV earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.